News

Fierce Biotech50m
Turkish private equity group invests $39M to support Harvard researcher’s next-gen obesity antibodies
Gökhan Hotamışlıgil, M.D., Ph.D., has secured about $39 million from a Turkish investment group to support the next 10 years ...